Swedish Pharma Stock News

OM:CORE A
OM:CORE AReal Estate

Corem Property Group Q1 2026 Net Loss Deepens Bearish Narratives On Earnings Outlook

Corem Property Group (OM:CORE A) has released its Q1 2026 numbers, posting revenue of SEK 799 million and a basic EPS loss of SEK 3.23, with trailing twelve month revenue at SEK 3.37 billion and a cumulative net income loss of SEK 3.29 billion over that period. Over the last six reported quarters, revenue has moved from SEK 915 million in Q4 2024 to SEK 896 million in Q1 2025 and then to SEK 799 million in Q1 2026, while quarterly basic EPS has ranged from a loss of SEK 0.07 in Q1 2025 to a...
OM:SAND
OM:SANDMachinery

Sandvik (OM:SAND) Q1 EPS Holds 3.09 SEK Testing Bulls’ High Growth Narrative

Sandvik (OM:SAND) opened Q1 2026 with revenue of SEK30.7b and basic EPS of SEK3.09, alongside net income of SEK3.9b, setting a straightforward baseline for the new financial year. The company has seen quarterly revenue move from SEK29.3b in Q1 2025 to SEK30.7b in Q1 2026, while basic EPS shifted from SEK2.98 to SEK3.09 over the same period, giving you a clear view of how the top and bottom lines are tracking into this quarter. With a trailing net profit margin recently reported at 12.1%, the...
OM:SKF B
OM:SKF BMachinery

Assessing AB SKF (OM:SKF B) Valuation After Q1 2026 Earnings Declines And Reorganisation Progress

AB SKF (OM:SKF B) has drawn investor attention after reporting first quarter 2026 earnings, with sales of SEK 21,873 million and net income of SEK 1,627 million, both lower than a year earlier. See our latest analysis for AB SKF. The latest earnings release and ongoing reorganisation around the separation of the Automotive business appear to be in focus for investors. The share price is at SEK247.6 after a 17.46% 1 month share price return and a 42.59% 1 year total shareholder return,...
OM:AFRY
OM:AFRYProfessional Services

European Dividend Stocks To Enhance Your Portfolio

As the pan-European STOXX Europe 600 Index shows positive momentum, with significant gains in Germany's DAX and France's CAC 40, investors are keenly observing corporate earnings amid geopolitical developments. In this context, dividend stocks present an attractive opportunity for those looking to enhance their portfolios by focusing on companies that offer reliable income streams and potential stability during uncertain economic times.
OM:ACAST
OM:ACASTInteractive Media and Services

European Companies Trading Below Estimated Value In April 2026

As European markets continue to digest corporate earnings and geopolitical developments, the pan-European STOXX Europe 600 Index has shown positive momentum, reflecting a broader sense of optimism among investors. In this environment, identifying undervalued stocks can be particularly appealing for investors seeking opportunities that may benefit from improving market sentiment and economic conditions.
OM:NREST
OM:NRESTHospitality

Exploring Three European Undiscovered Gems with Promising Potential

As European markets show resilience with the STOXX Europe 600 Index rising by 1.91% amid geopolitical developments and economic forecasts, investors are increasingly attentive to small-cap opportunities that might benefit from these broader trends. In this context, identifying stocks with strong fundamentals and growth potential becomes crucial for navigating the evolving landscape, particularly those that can capitalize on regional industrial production gains and stable monetary policy...
OM:EQT
OM:EQTCapital Markets

EQT Chair Handover To Jean Eric Salata Puts Global Growth In Focus

EQT AB (OM:EQT) has nominated Jean Eric Salata as the next Chairperson of the Board. Salata is set to succeed current Chairperson Conni Jonsson. The nomination signals an upcoming leadership transition at the top of EQT's governance structure. EQT AB, listed as OM:EQT, operates as an investment manager with a focus on private markets and fund management. A change in the chairperson role sits at the core of how the board oversees capital allocation, risk, and long term priorities, so many...
OM:SOBI
OM:SOBIBiotechs

Does Health Canada’s EMPAVELI Approval in C3G and IC-MPGN Change The Bull Case For Sobi (OM:SOBI)?

Swedish Orphan Biovitrum (Sobi) and partner Apellis Pharmaceuticals have received Health Canada approval for EMPAVELI (pegcetacoplan) to treat rare kidney diseases C3 glomerulopathy and primary IC-MPGN in patients aged 12 and older, based on Phase 3 VALIANT data showing reduced proteinuria, stabilized kidney function, and clearance of C3 deposits. This decision extends EMPAVELI’s nephrology footprint beyond the US and EU into Canada, adding another rare-disease indication to Sobi’s portfolio...
OM:SKF B
OM:SKF BMachinery

What AB SKF (OM:SKF B)'s Mexico Plant Closure and Production Shift Means For Shareholders

AB SKF recently announced it will close its shared Automotive and Industrial factory in Monterrey, Mexico, shifting production to its Puebla and La Silla plants as part of the ongoing separation of its Automotive business and a consolidation of its Americas manufacturing footprint. This reconfiguration responds to lower-than-anticipated electric vehicle demand and aims to align capacity with each division’s needs while incurring about SEK 0.50 billion in consolidation costs and cutting...